Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Outpatient Prescription Pattern of Anti-inflammatory Drugs by Pediatricians and ENT Physicians in Ulsan City

울산 지역 소아청소년과 및 이비인후과에서의 항염증제 처방 형태 분석

  • 김성철 (영남대학교 임상약학대학원) ;
  • 김영록 (영남대학교 임상약학대학원) ;
  • 황재윤 (영남대학교 약학대학) ;
  • 장현욱 (영남대학교 약학대학) ;
  • 남두현 (영남대학교 약학대학)
  • Received : 2010.10.20
  • Accepted : 2010.12.09
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The prescription sheets for outpatients from July 2008 to June 2009 from 7 community pharmacies in Ulsan City were surveyed for the anti-inflammatory drug (AID) prescription pattern. The AID prescription rate of pediatricians and ENT physicians were 30.0% and 34.8%, respectively. The oral steroidal anti-inflammatory drugs (SAIDs) were prescribed as much as 3.9% by pediatricians and 10.3% by ENT physicians. The chiefly prescribed oral SAID was prednisolone in pediatric clinics and methylprednisolone in ENT clinics. Meanwhile the prescription rate of oral non-steroidal anti-inflammatory drug (NSAID) was 22.5% by pediatricians and 21.4% in ENT physicians. The most favorable NSAIDs were propionate derivatives in both clinics. In case of externally-applied SAIDs, the prescription rate of pediatricians was 3.6% and that of ENT physicians was 2.8%. Among them, nasal spray, inhalant and gargle formulations for upper respiratory infection (URI) treatment occupied 35.8% of externally-applied SAIDs in pediatric clinics and 59.7% in ENT clinics. Further, it was observed that ENT physicians favored much stronger SAIDs in Group III of ATC classification (75.4% of externally-applied SAIDs) than pediatricians (49.2%). In the survey of AID combination rate, pediatric clinics showed much lower rate (1.4% of total AID prescriptions) than ENT clinics (7.5%). Among them, the combination rate of oral SAID and oral NSAID by ENT physicians (52.2% of total AID combinations) was much higher than pediatricians (36.6%), which might be over-prescription of AID agents. In conclusion, the AID prescription rate as well as AID combination rate, especially in SAID prescriptions, was much higher in ENT than pediatric clinics, which implies the higher confidency on AID drugs of ENT physicians even though the severity of patient's symptom could be considered.

Keywords

References

  1. Coico R, Sunshine G, and Benjamini E. Immunology-A Short Course, 6th ed. Wiely-Liss, 2009; 291-292.
  2. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (London) 1998; 94: 557-572. https://doi.org/10.1042/cs0940557
  3. Davidson FF and Dennis EA. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem Pharmacol 1989; 38: 3645-3651. https://doi.org/10.1016/0006-2952(89)90567-4
  4. Marina L, Matthew B, Jeremy S, and Andrew RC. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p3. Mol Cell Biol 2001; 21: 771-780. https://doi.org/10.1128/MCB.21.3.771-780.2001
  5. Ben G and Dianna W. In: The Endocrine System at a Glance, 2nd ed., Blackwell Publishing Ltd., 2006.
  6. 김지민, 박성환. 스테로이드 처방의 허와 실. 대한내과학회지 2009; 77: 298-303.
  7. Hilario MO, Terreri MT, and Len CA. Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors. J Pediatr (Rio J) 2006; 82: S206-S212. https://doi.org/10.1590/S0021-75572006000700011
  8. Berard A, Solomon DH, and Avorn J. Patterns of drug use in rheumatoid arthritis. J Rheumatol 2000; 27: 1648-1655.
  9. Price D, Bond C, Bouchard J, et al., International primary care respiratory group (IPCRG) guidelines: management of allergic rhinitis. Prim Care Respirat J 2006; 15: 58-70. https://doi.org/10.1016/j.pcrj.2005.11.002
  10. WHO Collaborating Centre for Drug Statistics Methodology. In: Guideline for ATC classification and DDD assignment 2010, 13th ed. 2009.
  11. http://en.wikipedia.org/wiki/Non-steroidal_anti-infla mmatory_drug
  12. 건강보험공단, 건강보험심사평가원. 2008년도 건강보험통계연보. 2009; 325.
  13. Siklar Z, Bostanci I, Atli O, and Dallar Y. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol 2004; 21: 561-563. https://doi.org/10.1111/j.0736-8046.2004.21508.x
  14. Findlay CA, Macdonald JF, Wallace AM, et al., Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ 2005; 317: 739-740.
  15. Guven A, Gulumser O, and Ozgen TJ. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse? Pediatr Endocrinol Metab 2007; 20: 1173-1182. https://doi.org/10.1515/JPEM.2007.20.11.1173
  16. 김성철, 박용철, 김보금, 남두현. 울산 지역 소아청소년과 및 이비인후과에서의 항생제 처방 형태. 임상약학회지 2010; 20: 145-150.